retatrutide mechanism triple agonist glp-1 gip glucagon phase 3 2025 Retatrutide Retatrutide, a GIP, GLP-1 and
Description
Hair loss has been reported by some patients on GLP-1 therapy, likely related to rapid weight loss and nutritional changes rather than a direct drug effect
01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)
Klil-Drori, A
In my world of sports medicine and active adult care, long-term success still depends on protecting muscle, building sustainable eating patterns, and maintaining movement capacity
Am J Physiol Endocrinol Metab (2001) 280:E4439
Cell Metab, 21 ,
Gastroparesis can significantly impact nutritional status and quality of life, with diabetes mellitus being the most common identifiable cause in the United States
